VIQ in Medicine

15/05/2026

𝗣𝗖𝗢𝗦 𝗶𝘀 𝗡𝗼𝘄 𝗣𝗠𝗢𝗦:

A historic change in women’s health:

PCOS (Polycystic O***y Syndrome) has officially been renamed to Polyendocrine Metabolic Ovarian Syndrome (PMOS) after 14 years of global collaboration involving experts, researchers, and thousands of patients worldwide.

The previous name was considered misleading because many women with the condition do not actually have ovarian cysts. Experts say the old term reduced a complex hormonal and metabolic disorder to only “ovaries” and “cysts,” contributing to delayed diagnosis, poor awareness, stigma, and inadequate treatment.

PMOS better reflects the true nature of the condition, including its effects on:
• Hormones and endocrine function
• Weight and metabolism
• Fertility and reproductive health
• Skin and hair changes
• Mental health

The condition affects nearly 1 in 8 women globally, more than 170 million people worldwide.

More than 50 international medical and patient organizations participated in the renaming effort, and over 22,000 survey responses helped shape the final decision. Experts hope this change will improve awareness, encourage earlier diagnosis, advance research, and ensure women receive more comprehensive care instead of having their symptoms dismissed for years.

15/05/2026

Peak inspiratory pressure (PIP) is the highest airway pressure reached during inspiration when a mechanical ventilator delivers a breath.

15/05/2026

Not every microcytic anemia is iron deficiency.

The Mentzer Index remains a useful bedside screening tool:
📌 >13 → IDA
📌

12/03/2026

Diagnosis of Coeliac Disease: Key Points from the 2025 Guidelines

1️⃣ Initial Serologic Testing
•First-line: IgA anti-tissue transglutaminase (tTG-IgA)
•Simultaneously: Total IgA to identify IgA deficiency
•If IgA deficient: Use IgG-based assays:
•tTG-IgG
•Deamidated gliadin peptide IgG (DGP-IgG)
•Note: Stool or saliva antibody tests are not recommended due to limited accuracy.

2️⃣ Confirmatory Testing
•Positive serology should be followed by upper endoscopy with duodenal biopsy.
•Biopsy recommendations:
•At least 6 biopsies
•From at least 2 locations: duodenal bulb and distal duodenum
•Histologic features:
•Villous atrophy
•Crypt hyperplasia
•Increased intraepithelial lymphocytes

3️⃣ Non-Biopsy Diagnosis (Selected Adults)
•Can be considered if all the following criteria are met:
•tTG-IgA ≥10× upper limit of normal
•Confirmatory positive serology
•Compatible clinical presentation
•Typically adults

23/12/2025